Novartis takes aim at Roche's star MS drug

Swiss drugmaker Novartis on Friday stepped up its challenge to Roche's multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its cross-town rival's drug Ocrevus.


from Reuters: Health News https://ift.tt/2ML3o2v

Comentarii

Trimiteți un comentariu

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Imagine
At Catholic Charities Opportunity Center in downtown St. Paul, Senior Clinical Manager Stacie Joncas works with some of the people who’ve been hardest hit by the many crises that have befallen the Twin Cities over the last few months. “These are people who are really having a rough time right now,” she said. “With the murder of George Floyd, the riots and COVID, what we’re finding is a huge increase in mental health and substance use problems among our client population.” A day center for people experiencing homelessness and for members of other vulnerable communities, the Opportunity Center provides a safe place for people to spend time, eat a hot meal and get help with a variety of issues, including looking for a job, finding affordable housing and getting support for mental health and addiction concerns. When COVID-10 hit Minnesota this spring, most health care providers made the shift to telehealth as a way to safely see their patients without risk of spreading the virus. While...
Citiți mai multe

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

MinnPost provides updates on coronavirus in Minnesota Sunday through Friday. The information is published following a press phone call with members of the Walz administration or after the release of daily COVID-19 figures by the Minnesota Department of Health. Here are the latest updates from September 11, 2020: 82,716 confirmed cases; 1,897 deaths Thirteen more Minnesotans have died of COVID-19, the Minnesota Department of Health said Friday, for a total of 1,897. It was the second day in a row with more than 10 reported deaths — something that’s only happened one other time since June 19 and 20. Of the people whose deaths were announced Friday, three were in their 90s, six were in their 80s, three were in their 70s and one was in their 60s. Seven of the 13 deaths announced Friday were among residents of long-term care facilities. Of the 1,897 COVID-19 deaths reported in Minnesota, 1,382 have been among residents of long-term care. The current death toll only includes Minnesota...
Citiți mai multe

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Cattle producers purchased 42 percent of all medically important antibiotics sold for livestock use in the United States in 2018 — about the same amount sold for chicken and pork production combined, according to a scathing  report published this month by the Natural Resources Defense Council (NRDC). In fact, in 2018, nearly as many antibiotics of medical importance were sold for use in cattle (5.6 million pounds) as for human use (7.5 million pounds). Most of those antibiotics wouldn’t be necessary if the U.S. beef industry made changes in how they raise cattle and produce meat. Cattle producers in the U.S. use antibiotics three to six times more intensively than do their counterparts in the European Union, the report points out. That’s because the drugs are fed routinely to cattle on U.S. feedlots — even when no animals are sick. The European Union, which is the third-largest beef producer globally, not only discourages the routine feeding of antibiotics to cattle, it has an...
Citiți mai multe